Flat Medical, a developer of precision positioning solutions, announced significant milestones for its EpiFaith® Smart Syringe in the European market.

• UK & France Milestone: Through local distributors, the company won a landmark tender from the UK National Health Service (NHS) on January 13 (contract effective July 1). Simultaneously, it secured a major order from AP-HP (Assistance Publique – Hôpitaux de Paris), the largest hospital system in Europe.
• Market Impact: CEO Dr. Wen-Fu Lo noted that NHS and AP-HP recognition validates the product's clinical performance and economic benefit. The NHS win is expected to trigger procurement momentum across other EU member states that follow public health benchmarks.
• Global Momentum (2025–2026):
• North America: Exponential sales growth and deepening ties with top-tier teaching hospitals.
• Middle East: Formal contracts signed in the UAE, with initial orders received from Israel and Lebanon.
• Japan & Mainland Europe: Commercialization is underway in Japan, supported by a growing distribution network across the European continent.

Resource: 醫盟科技歐洲佈局傳捷報： EpiFaith® 獲英國NHS標案並進入歐洲最大醫院體系